These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10403352)

  • 1. Determinants of retinopathy progression in type 1 diabetes mellitus.
    Cohen RA; Hennekens CH; Christen WG; Krolewski A; Nathan DM; Peterson MJ; LaMotte F; Manson JE
    Am J Med; 1999 Jul; 107(1):45-51. PubMed ID: 10403352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus.
    Marshall G; Garg SK; Jackson WE; Holmes DL; Chase HP
    Ophthalmology; 1993 Aug; 100(8):1133-9. PubMed ID: 8341492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group.
    Arch Ophthalmol; 1990 Sep; 108(9):1234-44. PubMed ID: 2119168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sorbinil retinopathy trial: neuropathy results. Sorbinil Retinopathy Trial Research Group.
    Neurology; 1993 Jun; 43(6):1141-9. PubMed ID: 8170559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitus. Sorbinil Retinopathy Trial Research Group.
    Christen WG; Manson JE; Bubes V; Glynn RJ
    Am J Epidemiol; 1999 Dec; 150(11):1142-51. PubMed ID: 10588075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to quantify the relation between disease progression in paired eyes.
    Glynn RJ; Rosner B
    Am J Epidemiol; 2000 May; 151(10):965-74. PubMed ID: 10853635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1998 Jul; 116(7):874-86. PubMed ID: 9682700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Serum Cholesterol Increases Risk for Development and Progression of Nonproliferative Retinopathy in Patients with Type 1 Diabetes Without Therapeutic Intervention: Prospective, Observational Study.
    Bulum T; Tomić M; Duvnjak L
    Arch Med Res; 2017 Jul; 48(5):467-471. PubMed ID: 29089151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval between onset of mild nonproliferative and proliferative retinopathy in type I diabetes.
    Vitale S; Maguire MG; Murphy RP; Hiner C; Rourke L; Sackett C; Patz A
    Arch Ophthalmol; 1997 Feb; 115(2):194-8. PubMed ID: 9046254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.
    Klein R; Klein BE; Moss SE; Cruickshanks KJ
    Ophthalmology; 1998 Oct; 105(10):1801-15. PubMed ID: 9787347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cohort study of the relationship of diabetic retinopathy to blood pressure.
    Klein BE; Klein R; Moss SE; Palta M
    Arch Ophthalmol; 1995 May; 113(5):601-6. PubMed ID: 7748130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.
    Lloyd CE; Klein R; Maser RE; Kuller LH; Becker DJ; Orchard TJ
    J Diabetes Complications; 1995; 9(3):140-8. PubMed ID: 7548977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cigarette smoking with diabetic retinopathy.
    Moss SE; Klein R; Klein BE
    Diabetes Care; 1991 Feb; 14(2):119-26. PubMed ID: 2060413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
    Matthews DR; Stratton IM; Aldington SJ; Holman RR; Kohner EM;
    Arch Ophthalmol; 2004 Nov; 122(11):1631-40. PubMed ID: 15534123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
    Engerman RL; Kern TS
    Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy during pregnancy.
    Axer-Siegel R; Hod M; Fink-Cohen S; Kramer M; Weinberger D; Schindel B; Yassur Y
    Ophthalmology; 1996 Nov; 103(11):1815-9. PubMed ID: 8942876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking and ten-year progression of diabetic retinopathy.
    Moss SE; Klein R; Klein BE
    Ophthalmology; 1996 Sep; 103(9):1438-42. PubMed ID: 8841303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure and the progression of mild background diabetic retinopathy.
    Chahal P; Inglesby DV; Sleightholm M; Kohner EM
    Hypertension; 1985; 7(6 Pt 2):II79-83. PubMed ID: 4077241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.